Physician profile
Amanda E Steele
NPI 1285305094
$5,785.21
in general payments reported to CMS, 2019-2025
31 companies · $1,145 in 2025
The $1,145 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.97 · 2022: $1,954 · 2023: $1,497 · 2024: $1,161 · 2025: $1,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,368 · Travel and Lodging: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,368.17 |
| Travel and Lodging | $435.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,199.05 | 2022-2025 | General - Pain Management |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,086.87 | 2022-2025 | Relistor |
| Abbvie INC. | $701.71 | 2022-2025 | |
| Pacira Pharmaceuticals Incorporated | $501.98 | 2023 | Iovera, Zilretta |
| Pfizer INC. | $368.78 | 2023-2025 | |
| Azurity Pharmaceuticals, INC. | $297.57 | 2023-2025 | Horizant, Horizant |
| Collegium Pharmaceutical, INC. | $282.03 | 2021-2025 | Xtampza, Belbuca |
| Stryker Corporation | $169.47 | 2024 | Mako |
| Medtronic, INC. | $156.10 | 2022-2025 | Intellis Adaptivestim |
| Biohaven Pharmaceutical Holding Company Ltd. | $149.13 | 2022 | |
| Spinal Simplicity, LLC | $94.12 | 2024-2025 | Ha Minuteman G3-R |
| Protega Pharmaceutials INC | $87.95 | 2025 | Roxybond |
| Nalu Medical, INC. | $80.48 | 2024-2025 | Nalu Neurostimulation System |
| Valinor Pharma, LLC | $59.61 | 2023-2025 | Movantik |
| Uswm, LLC | $58.44 | 2022-2023 | Zimhi, Lucemyra |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $54.83 | 2022-2025 | Ztlido |
| Averitas Pharma INC. | $45.95 | 2023 | Qutenza |
| Nevro Corp. | $42.56 | 2023 | Senza |
| Painteq LLC | $41.22 | 2024 | Painteq |
| Almatica Pharma LLC | $36.43 | 2022 | |
| Hikma Pharmaceuticals USA | $33.91 | 2022-2023 | Kloxxado |
| Foundation Fusion Solutions, LLC | $31.66 | 2024-2025 | |
| Saluda Medical Americas, INC. | $31.06 | 2025 | Evoke |
| Horizon Therapeutics Plc | $29.13 | 2022 | |
| Globus Medical, INC. | $28.12 | 2025 | Senza |
| Arbor Pharmaceuticals, INC. | $24.89 | 2021-2022 | |
| Bioventus LLC | $24.45 | 2023 | Durolane |
| Spr Therapeutics, INC | $21.43 | 2024 | Sprint Pns System |
| Vertex Pharmaceuticals Incorporated | $20.73 | 2025 | |
| Tonix Medicines, INC. | $13.70 | 2025 | Zembrace Symtouch |
| Avanos Medical | $11.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Steele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.